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ABSTRACT 
 This work started with the aim to synthesize monomeric ring-opened analogues of 
the palladacycles [(2-iminoisoidoline)PdCl(PCy3)] incorporating iminoisoindoline and 
phosphine ligands, and evaluate their catalytic activities in C-C coupling reactions 
compared to their monomeric palladacyclic precursors. This project further evolved to 
investigate cyclic peptides derived from flaxseed oil as alternative ligands in palladium 
coordination chemistry for applications in C-C coupling reactions. During the course of 
our studies, we observed that cyclic peptides derived from flaxseed oil had a high affinity 
for first row transition metals. 
 In the first project, ring-opened analogues of iminoisoindoline-based 
palladacycles [(2-iminoisoidoline)PdCl(PCy3)] were synthesized, characterized and 
investigated for catalytic activities in Suzuki C-C coupling reactions. Iminoisoindoline-
based monomeric palladacycles synthesized in our group showed reasonable activity in 
Suzuki coupling reactions of aryl halides and phenyl boronic acids in general. However, 
when deactivating groups were involved on the coupling substrates, or the steric 
hindrance of the coupling substrates were increased, the catalytic activity decreased 
drastically. The objective of this work was thus to synthesize monomeric ring-opened 
iminoisoindoline-based palladium complexes derived from the analogous monomeric 
palladacycles and compare their activity in Suzuki coupling reactions to that of the initial 
palladacycles. This work represents the only known example of direct ring-opening of a 
well-defined monomeric palladacycle into its ring-opened analogue to date. Catalytic 
activity of the ring-opened palladium complexes were evaluated with Suzuki coupling 
reactions, and the catalytic activity remained outstanding even with deactivating groups 
iv 
 
or increased steric hindrance on the substrates. Moreover, this catalyst was even active in 
the presence of water. 
 The second project is a study of the coordination chemistry of cyclic peptides 
derived from flax oil with palladium precursors and further applied to other analogous 
transition metals complexes. Saskatchewan has the highest contribution to national flax 
production, and flax is an affordable crop with a high nutrition value. The bitter flavor 
originates from the cyclic peptides in the flaxseed oil and is the reason why flaxseed oil is 
not widely commercialized as a cooking oil. Very few examples from literature report the 
interaction of cyclic peptides with transition metals, and no study of this particular class 
of cyclic peptides derived from flax oil with transition metals has been reported. With 
that being said, we investigated the interaction between this naturally occurring ligand 
and transition metal precursors such as palladium, to determine if a coordination complex 
could form. We successfully observed new cyclic peptide based metal complexes 
forming with palladium and platinum used as precursors, with relatively harsh reaction 
conditions being required.  In contrast, Cu and Fe-based complexes incorporating CLA 
(Cyclolinopeptide A) formed virtually instantaneously upon the introduction of CLA to 
the metal under mild conditions. Moreover, it was surprising to observe fast reduction of 
Fe(III) and Cu(II) species to their corresponding Fe(II) and Cu(I) analogues, with no such 
examples in literature reported before. 
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Chapter 1. Introduction 
1.1 Palladacycles 
1.1.1 Definition of Palladacycles 
In general, a palladacycle (Figure 1.1) can be defined as any palladium 
compound containing one palladium–carbon bond intramolecularly stabilized by one 
or two neutral donor atoms (Y), where the organic moiety acts as a C-anionic four-
electron donor ligand or as a C-anionic six-electron donor ligand.1 
 
Figure 1.1. Structural definition of a palladacycle 
 
 It is important to note that in order to be referred as palladacyclic species there 
should be at least one Pd-C bond in the cyclic structure where a palladium atom is 
incorporated into. (Figure 1.2).
1
 
 
 
Figure 1.2. Examples of a non-palladacyclic and a palladacyclic complex 
2 
 
1.1.2 Evolution of Palladacycles 
 It has been exactly fifty years since the discovery of palladacycles. In 1965, 
Cope and his coworkers carried out reactions of azobenene or its derivatives with 
Li2PdCl4 or PdCl2, to afford the first isolated, well-characterized palladacycles 1a, 1b 
and 1c (Scheme 1.1). 
2
 
 
Scheme 1.1. First palladacycles made in 1965 by Cope and coworkers 
 
 Until 1995, palladacycles were considered only to be intermediates in catalytic 
reactions.3, 4 It was Herrmann et al. who isolated cyclopalladated tri-o-tolyl-phosphine 
complex 2 (Scheme 1.2) and were the first to test it as a catalyst precursor for Pd-
catalyzed Heck and other cross-coupling reactions. The Herrmann complex is air, 
moisture, and thermally stable, as well as commercially available.5 The discovery of 
the Herrmann Complex raised high expectations for this class of compounds, as these 
species could activate more economic substrates than those applied for coupling 
reactions thus far (aryl iodides or aryl triflates), such as aryl chlorides, hence, 
potentially enabling industrial application of these cross-coupling reactions mediated 
by palladacycle catalysts.6 Since then, palladacycles have been ubiquitous in catalytic 
transformations, playing significant roles as catalyst precursors or active 
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intermediates.7-13 
 
 
Scheme 1.2. The first palladacycle (2) used as a pre-catalyst in carbon-carbon (C-C) 
cross-coupling reactions, widely known as “the Herrmann Complex” 
 
 
1.2. Application of palladacycles in Suzuki-Miyaura Carbon-Carbon cross-
coupling reactions 
1.2.1 Brief introduction of Suzuki reaction 
 To avoid redundancy, Suzuki-Miyaura Carbon-Carbon cross-coupling 
reactions will be abbreviated as Suzuki reactions in this thesis. Collectively, Pd-
catalyzed coupling reactions represent some of the most powerful and versatile tools 
available to synthetic organic chemists. Their widespread popularity stems from the 
fact that they are generally tolerant to a large number of functional groups, which 
allows them to be employed in a wide range of applications.
14
 In fact, no other 
transition metals can offer such versatile methods for C-C bond formations as Pd.15 
Palladacycles, as a class of palladium-based complexes, weren’t investigated as a pre-
catalyst in C-C cross coupling reactions until Herrmann et al. evaluated the catalytic 
activity of 2 in 1995,5 and since then, these compounds have experienced a 
renaissance that has been fundamental in the recent development of homogeneous 
catalysis, particularly in the case of C-C cross coupling reactions. Other important 
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areas where palladacycles have found recent applications include their use as 
mesogenic16-23 and photoluminescent23-33 agents, as well as biological applications for 
cancer treatment. 34, 35 
 
 Arguably, among palladacycle-catalyzed cross coupling reactions, the Suzuki 
reaction of aryl and vinyl halides/triflates with boronic acids is emerging as a 
favorite,
36-40
 and it has been applied industrially to the production of compounds such 
as losartan,
 41
 a Merck
®
 antihypertensive drug. This popularity is attributable to a 
variety of factors, and the following six advantages account for the Suzuki reaction 
being the most popular among palladium-catalyzed cross-coupling reactions. 
 
 
1. Commercial availability of a large number of boronic acids 
2. Stability of boronic acids to heat (up to 110 
o
C), air, and moisture 
3. Tolerance to a broad range of functional groups 
4. Mild reaction conditions 
5. Low toxicity (but not non-toxic) 
6. Easy separation of inorganic boronic byproducts from reaction mixture 
 
 A general equation of Suzuki reaction is shown in Scheme 1.3, and its general 
mechanism is shown in Scheme 1.4.1 
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Scheme 1.3. A general expression of Suzuki reaction 
 
 
Scheme 1.4. General mechanism for Suzuki reaction  
 
1.2.2 Obstacles of coupling aryl chloride substrates in Suzuki reactions 
 The Suzuki reaction is an extremely powerful method for the formation of 
biaryl compounds.
36, 39, 40
 However, for many years a major limitation of the Suzuki 
reaction has been the poor reactivity of aryl chlorides, which from the standpoints of 
cost and availability are more attractive substrates than the corresponding bromides, 
iodides, and triflates. Traditional palladium/triarylphosphine catalysts are only 
effective for the coupling of certain activated aryl chlorides (for example, heteroaryl 
chlorides and substrates that bear electron-withdrawing groups), but not for aryl 
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chlorides in general. The low reactivity of chlorides is usually attributed to the 
strength of the C-Cl bond (bond dissociation energies for Ph-X: Cl: 96 kcal/mol; Br: 
81 kcal/mol; I: 65 kcal/mol).42, 43 Consequently, there has been considerable attention 
focused on the development of catalysts that are able to promote the coupling of aryl 
chloride substrates. Their reluctant oxidative addition to Pd(0) centers is usually the 
rate limiting step in Pd-catalyzed coupling reactions.42, 44 
 Major breakthrough has been achieved by a number of research groups in last 
two decades: catalysts based on bulky, electron-rich phosphines (and carbenes) have 
proven to be particularly effective and versatile.14, 45 Rather than exhaustively list all 
the reported palladacycles for aryl chloride coupling reactions, this work aims to 
provide insights about the catalyst design philosophy based on varying the bulk and 
electron-donating ability of phosphines. 
 
1.2.3. Phosphine-based palladacycles 
1.2.3.1 Brief introduction of phosphines 
 There are many phosphine-involved Pd-based catalytic systems that can be 
used to catalyze Suzuki reactions, and in synthetic laboratories those are typically 
employed by in situ formation from an appropariate Pd(0) or Pd(II) precursor and a 
triarylphosphine.
11
 The role of electron-rich phosphines in the mechanism of Suzuki 
reaction is to accceleate the rate limiting oxidative addition step of aryl halides; the 
role of the bulkiness of a phosphine assists facile reductive elimination, which is the 
last step in the catalytic cycle of a Suzuki reaction. The most intuitive method to tell if 
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one particular phosphine is a strong electron donating ligand is to check the pKa value 
of the conjugate acids of this very phosphine; the higher the pKa, the stronger a Lewis 
base this phosphine is. The pKa values of commonly used phosphines are:  
P(tBu)3 (11.4), PCy3 (9.7), P(nBu)3 (8.4), PPh3 (2.7).
15
  Triphenylphosphine is the 
most affordable phosphine, and it is air stable; however, its relatively low electron-
donating ability makes the resulting Pd complexes less active, especially when aryl 
chloride substrates are used. Tricyclohexylphosphine is more expensive than 
triphenylphosphine and air sensitive, however, its much higher pKa makes it arguably 
the most popular phosphine to be used in palladium-based catalytic systems for 
Suzuki reactions.
1, 11, 15
 Tri-tert-butylphosphine is supposed to be the most ideal bulky, 
electron donating phosphine based on its structure and pKa value (11.4), and in many 
cases it has proven to be highly active in Pd-based systems for Suzuki reactions; 
however, it is extremely air sensitive and based on what literature had indicated only 
research groups with world-class expertise in air-sensitive operation such as the Fu 
group from CalTech (The relevant work by the Fu group was performed when the Fu 
group was in MIT) grew quite fond of it, making it less practical for average research 
groups to utilize its potential, not to mention industrial application.
11, 15, 45, 46
 
 Since 1998, dialkyl(o-biphenyl)phosphine pioneered by the Buchwald group 
from MIT had drawn great attention as these phosphines-involved Pd-based catalytic 
systems showed very promising activity in Suzuki reactions, even at room 
temperature.
47
 The efficiency of these dialkyl(o-biphenyl)phosphine ligands was 
attributed to their relatively high basicity, which would facilitate oxidative addition; 
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their size and the fact that the secondary ring of the biphenyl function may coordinate 
to the palladium centre(s). After one decade of development of dialkyl(o-
biphenyl)phosphines, Buchwald et al. have made a portfolio of dialkyl(o-
biphenyl)phosphines; moreover, with numerous experiments the efficacy of 
phosphine could be predicted by the functional group on the phosphine (Figure 1.3), 
which is remarkable because in general, roles of phosphines are not entirely 
understood and their performance is not always predictable.
49 
Buchwald and co-
workers have thoroughly studied dialkylbiarylphosphines in Pd-catalyzed C-C 
coupling reactions from 1998 to 2008.
47, 48
 
 
 
Figure 1.3. Structural features of the dialkylbiarylphosphines and their impact on the 
efficacy of catalysts using these ligands. This figure is adapted from reference 48. 
 
1.2.3.2 Phosphine adducts of palladacycles 
 As mentioned in chapter 1.2.3.1, “classical” methods of employing phosphines 
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in Pd-based C-C coupling reactions involved in situ formation of the active catalyst 
from an appropriate Pd(II) or Pd(0) precursor and a triarylphosphine. Unfortunately, 
while useful, these classical catalyst systems suffer from two major limitations: first, 
in general, they need to be used in high loadings, typically a few mol% Pd. Second, 
they show little or no activity with aryl chloride substrates. High loading of Pd 
catalysts makes their application in fine chemical or pharmaceutical industries less 
appealing because the palladium contamination of the product must be in the low ppm 
region, and the resulting nessary product clean-up is expensive. This, coupled with the 
high price of not only the palladium but often the ligands, can make the whole process 
prohibitevly expensive.
 11
 
 Therefore, in situ formation of the active catalyst is not the best idea to fully 
utilize the potential of Pd-based complexes, that is why well-defined palladacycles 
with triarylphosphine ligands have become a popular topic of research. Well-defined 
palladacycles have several advantages than the in situ formed Pd catalysts: 
 1. With rigid ring structure, palladacycles could potentially be more air 
and thermally stable than commerically available commonly used Pd precursors such 
as PdCl2, Pd(OAc)2, Pd(PPh)4, Pd2(dba)3. 
 2. Loading of palladacycles is significantly reduced compared to the in 
situ formation of the active Pd catalyst, making it more appealing in low ppm Pd(0) 
residue applications. 
 3. Development of the palladacycles and evaluation of their catalytic 
performance benefits chemical understanding of how the structure and functional 
10 
 
goups on the palladacycles would tune their catalytic efficacy, while in situ formation 
of the active Pd catalyst provides limited insights for the catalysis as the only thing 
can be altered in the catalytic design is the ratio between the Pd precursor and the 
triarylphosphine. 
 Therefore, we reason that palladacycles can act as an air-stable, a robust and  
clean source for the highly efficient delivery of low-coordinate Pd(0) phosphine 
species, and the design of the Pd pre-catalyst tend to be palladacycles incorporating 
triarylphosphine ligands. In 2001 Bedford and co-workers pioneered N-based 
palladacycle 4 (Scheme 1.5) which is extremely active for Suzuki coupling reactions 
and is the highest reactivity record holder in terms of turn over number (TON, TON = 
𝑚𝑜𝑙 𝑝𝑟𝑜𝑑𝑢𝑐𝑡
𝑚𝑜𝑙 𝑐𝑎𝑡𝑎𝑙𝑦𝑠𝑡
 ) for coupling aryl chlorides, and it even surpassed the previous highest 
record holder from the Buchwald group by 20 times.
50
 It is worth mentioning that the 
catalytic system from the Buchwald group was still using the in situ method (Scheme 
1.6)
51
, and this sharp contrast is a good demostration that development of well-defined 
palladacycle is the future of catalyst design. Selected reactions highlighting the 
catalytic performance of complex 4 are shown in Table 1.1. 
 
 
Scheme 1.5. Synthesis of super active N-based palladacycle by Bedford group.
50
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Scheme 1.6. Buchwald’s in situ Pd-dialkyl(o-biphenyl)phosphine catalytic system as 
the previous highest TON holder for coupling aryl chlorides.
51
 
 
Table 1.1. Select results of aryl chloride coupling from Bedford’s highly active 
palladacycle 4. 
 
Entry Substrate Cat % Conversion (%) TON 
1 
 
0.01 80 8000 
2 
 
0.01 100 10000 
3 
 
0.01 100 10000 
4 
 
0.001 99 99000 
 
 As can be seen from Table 1.1, palladacycle 4 is highly active for activited 
substrates with electron-withdrawing groups para to the chloride that quantitative 
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conversion was always observed even at extreme low loading. Impressively 
palladacyle 4 is also very active even at very low loading for deactivited groups with 
electron-donating group para to the chloride, which is difficult for the coupling 
reaction because of the increased electron density on the Ar-Cl bond. It is noticable 
that caesium carbonate as the base and 1,4-dioxane as the solvent is the best 
combination for the Bedford system, and subsquently became the standard in 
evaluating Pd-based systems in C-C coupling reeactions.
52-55
 Bedford’s system 
addressed several highlights for the design of a highly active Pd-based catalytic 
system for coupling aryl chlorides: (i) a well-defined palladacycle incorporating 
tricyclohexylphosphine ligands; (ii) N-based palladacycles (which seems to be a more 
promising choice than S-based or O-based palladacycles based on literature); (iii) a 
monomeric palladacycle is more preferable than a dimeric palladacycle (dimeric 
palladacycle 3 is less active than monomeric palladacycle 4
50 
and thus coupling 
results using 3 is not shown in Table 1.1). 
 
1.3 Ring-opening of monomeric palladacycles 
 The use of phosphine-based compounds to split dimeric palladacyclic 
complexes has been known since the 1970s.
56
 One more achievement that wasn’t 
mentioned in chapters 1.2.3.2 about Bedford’s palladacycle 4 is that it is the very first 
time the catalytic activity of a resultant monomeric palladacycle was evaluated in a C-
C coupling reaction and a direct comparison was made between the monomeric 
palladacycle and its dimeric precursor to prove that improved activity could be 
13 
 
achieved by splitting a dimeric palladacycle into its monomeric analogues using PCy3. 
Surprisingly, very few palladacycles have been ring-opened with Lewis bases to yield 
their well-defined acyclic analogues. The Bedford group has converted a dimeric 
palladacycle to its monomeric acyclic analogues using a thioether-based palladacycle; 
however, in their system the monomeric monophosphine ligated palladacyclic species 
could not be formed (Scheme 1.7). The acyclic bisphosphine palladium complex was 
not reported to be investigated in C-C coupling reactions. The Likhar group has 
reported that a chloride-bridged dimeric benzothiophene-based palladacycle reacts 
with PPh3 or PCy3 to yield the acyclic bisphosphine analogue. As in the Bedford 
example, the monomeric monophosphine precursor could not be synthesized. 
Turnover numbers up to 184 were reported for the Suzuki coupling of 4-chloroanisole 
with phenylboronic acid for the ring-opened benzothiophene-based palladacycle 
(Scheme 1.8). The chloride-bridged dimeric benzothiophene-based palladacycle was 
not investigated in Suzuki coupling reactions.58 
 
Scheme 1.7. Synthesis of a ring-opened thioether-based palladium complex.50,57 
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Scheme 1.8. Synthesis of a ring-opened benzothiophene-based palladium complex.58 
 
1.4 Previous Work in Foley Group 
 Previous work by Dr. Jackson Chitanda from the Foley group reported a 
synthetic routine of N, N’-diaryliminoisoindoline-based dimeric palladacycle and its 
corresponding monomeric palladacyclic splitted by PCy3. Both dimeric and 
monomeric palladacycle were fully characterized, and the catalytic efficacy were 
evaluated for the dimeric palladacycle. The catalytic efficacy of the monomeric 
palladacycle were not explored, and ring-opening of monomeric palldacycle was not 
attempted.
 52-55
 
 
1.5 Research objectives 
 Our goal was to perform a direct comparison of catalytic activity of a well-
defined monomeric palladacycle and its well-defined ring-opened analogue, which 
has not been reported yet. By destabilizing a monomeric palladacycle through the 
ring-opening process using PCy3, we anticipate a significant increased activity for the 
Suzuki coupling reactions of aryl chlorides. Moreover, we expect the improved 
catalytic activity for the ring-opened analogue of a monomeric palladacycle extends 
to aryl chlorides with deactivated groups, as well as the coupling of bulky substrates.  
15 
 
1.6 Cyclicpeptide A 
1.6.1 Brief introduction of plant cyclopeptides 
 Plant cyclopeptides are defined as cyclic compounds formed mainly with the 
peptide bonds of 2-37 amino acid residues and discovered in higher plants.59 About 
455 cyclopeptides have been discovered from higher plants during the past half 
century, belonging to 26 families, 64 genera, and 120 species. On the basis of their 
structural skeletons and distribution in plants, Zhou et al. proposed the systematic 
structural classification of plant cyclopeptides which are divided into two classes, five 
subclasses, and eight types (Figure 1.4).59 
 
          Cyclopeptide Alkaloids (Type I) 
        Heteromonocyclopeptides    Depsicyclopeptides (Type II) 
              Heterocyclopeptides       Solanaceae-tyle Cyclopeptides (Type III) 
        Heterodicyclopeptides    Urticaceae-type Cyclopeptides (Type IV) 
Cyclopeptides          Compositae-type Cyclopeptides (Type V) 
        Homomonocyclopeptides 
              Homocyclopeptides       Caryophyllaceae-type Cyclopeptides (Type VI) 
        Homodicyclopeptides    Rubiaceae-type Cyclopeptides (Type VII) 
        Homopolycyclopeptides    Cyclotides (Type VIII) 
Figure 1.4. Classification of plant cyclopeptides based on structural differences. 
This figure is adapted from reference 59. 
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1.6.2 Cyclolinopeptide A from flaxseed oil 
1.6.2.1 Brief introduction of flaxseed and flaxseed oil 
 Flaxseed is one of the oldest cultivated crops and continues to be widely 
grown for oil, fiber and food.60 The average worldwide flaxseed production between 
2007 and 2011 was 1,862,449 tons.61 Saskatchewan is always the highest contributor 
for flaxseed production. For example in 2014/2015 Saskatchewan’s flaxseed 
production alone was 501.2 thousand tons, which was more than 60% of the total 
Canadian domestic production.62 Increasing demand for edible oil sources with 
significant percentages of omega-3 fatty acids is resulting in consumption of flaxseed 
as a functional food.63 
 
1.6.2.2 Cyclolinopeptide A from flaxseed oil 
 It is worth mentioning that the very first plant cyclopeptide, named 
cyclolinopeptide A, was isolated and determined from flaxseed by Kaufmann and 
Tobschirbel64 in 1959, and thus laid the foundation of plant cyclopeptides research. 
Cyclolinopeptide A (CLA) is under the category of Caryophyllaceae-type 
cyclopeptide (Type VI). The “lino” from the name is simply because of 
flax’s binomial name Linum usitatissimum; letter A reflects the chronological order of 
this particular cyclopeptide being discovered, which in this case means being the first. 
There are complications with respect to the nomenclature of cyclolinopeptides as 
more were discovered from 1999 to 2014 by different research groups and there 
hasn’t been a unified agreement in this area; Reaney et al. in 2015 summarized the 
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literature names of the cyclolinopeptides and proposed their new nomenclature system 
to avoid confusion.63 The only cyclopeptide that will be discussed in depth through 
this thesis is cyclolinopeptide A and since it is the very first discovered 
cyclolinopeptide, nomenclature would not be an issue. 
 
1.6.3 Applications of CLA 
 Since first being isolated from linseed by Kaufmann and Tobschirbel, 64 it only 
took five years for Professor Weygand to present the synthesis of CLA through 
classical solution methods, which was the only way known at that time for such 
“large” peptides.65, 66 In the early 1970’s CLA has been the object of intensive 
structural studies, with Naider et al. for Circular Dichroism (CD) studies, Brewster el 
al. for NMR studies, and Tenelli et al. for conformational energy calculations.67-69 
Likely reasons for motivation of intensive structural studies are CLA being the first 
isolated plant cyclopeptide, as well as the presence of two Pro residues which 
suggests that the accessible conformational space might be constrained compared to 
known medium-sized peptides.70 The amino acid sequence of CLA was determined as 
c(Pro-Pro-Phe-Phe-Leu-Ile-Ile-Leu-Val) from early structural studies.  
 In 1987 Di Blasio et al. were first to successfully obtain a crystal structure 
from X-ray studies of CLA.71 The author concluded that the solid state and solution 
conformations of CLA are essentially identical. Soon there had been several reports of 
CLA being crystallized from different solvent mixtures, leading to three different 
polymorphs: an orthorhombic form, grown from isopropanol–water, a monoclinic 
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form, grown from N,N-dimethylformamide (DMF)–isopropanol, and a triclinic form, 
grown from acetone–benzene. Remarkably, in spite of the different environments in 
which the crystals were grown, the cyclolinopeptide A molecules in all crystal forms 
show the same conformation. 71-73 A high resolution image of the crystal structure of 
CLA (Figure 1.5) was provided by Saskatchewan Structural Science Centre (SSSC) in 
their relative recent report of CLA’s X-ray study.74 
 
Figure 1.5. Crystal structure of CLA. This figure is adapted from reference 74. 
  
The elucidation of the 3D structure of CLA resulted in significant research 
interest towards its immunosuppressive studies since its Pro-Pro-Phe-Phe sequence is 
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shared with Antamanide (abbreviated as AA, shown in Figure 1.6),75 a homodetic 
cyclodecapeptide c(Pro-Pro-Phe-Phe-Val-Pro-Pro-Ala-Phe-Phe) isolated from the 
poisonous mushroom Amanita phalloides. Antamanide, one of the most extensively 
investigated cyclic peptides, received huge scientific attention because of its strong 
antidote activity against phallotoxins, a family of extremely toxic bicyclic 
heptapeptides isolated from the same source as AA itself.76 
 
 
Figure 1.6. Representation of Antamanide 
 
 Siemion et al. were the first to report CLA’s strong immunosuppressive 
activity in 1991.77 The influence of CLA on the humoral response was determined by 
the plaque forming cell test and the influence on the cellular immune response by the 
delayed-type hypersensitivity test. The effect of CLA in this test was comparable with 
that exerted by a known powerful immunosuppressant – cyclosporine A (Figure 
1.7).78 However, in the test of inhibiting calcium dependent activation of T 
lymphocytes, the dosage of CLA required to complete inhibition was ten times as high 
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as that of cyclosporine A.79, 80 
 
 
Figure 1.7. Representation of Cyclosporin A.79 
 
 As it had been mentioned above, CLA can be considered as an analogue of a 
cyclic decapeptide, Antamanide, which is also known for its ability to form complexes 
with metal ions of IA and IIA groups.81 In the case of CLA, this tendency for metal 
ions complexation is strongly reduced.82 It has been found that CLA binds with K+, 
Na+, Ca2+, Mg2+, and Ba2+ from NMR and CD (Circular Dichroism) studies, while 
binding affinity to Ba2+ being the strongest. It was indicated by CD data that 
depending on the concentration, two types of such complexes are present in 
acetonitrile solution: 1 : 2 sandwiches and 1 : 1 equimolar complexes. NMR data were 
consistent with an equimolar form. Addition of bivalent metal ions to the CLA 
solution induces drastic structural changes. In the equimolar Ba2+/CLA complex the 
peptide backbone contains all-trans peptide bonds and the global shape of the 
complexed peptide can be described as a bowl with a polar concave side hosting Ba2+ 
and the opposite convex side predominantly apolar.83 To the best of our knowledge, 
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no application of resulting metal ion complex binding with CLA has been reported. 
 
1.6.4 Research objectives 
 As mentioned previously, the applications of CLA to date have been limited. 
There were a few reports of its immunosuppressive properties and ion binding 
properties with few selected ions. As a matter of fact, a SciFinder® search performed 
on April 15, 2015 showed only 190 articles contained the concept of 
cyclolinopeptides; the majority of the articles were based on the structural studies of 
CLA, the synthesis of CLA derivatives, and immunosuppressive studies of CLA and 
its derivatives. Very few articles got cited more than 10 times, even for review 
articles, and there is no example showcasing CLA coordinating with transition metals. 
As organometallic chemists, we believe that there is much of CLA being unexplored: 
we would envision CLA as a naturally occurring, non-toxic, large-sized ligand that 
could allow transition metals to possibly have multiple binding sites on CLA. It is 
highly anticipated that we could make a well-defined Pd complex incorporating CLA 
and commercially available Pd precursors, and the catalytic activity of certain C-C 
coupling reactions of this well-defined Pd complex could be significantly improved 
than the Pd precursors alone. It is also envisaged that if a Pt complex incorporating 
CLA and Pt precursors could be successfully synthesized, this Pt complex should 
exhibit interesting properties in cytotoxicity studies as Pt-based complex had shown 
promising results in cancer treatments. If we explore further, first row transition 
metals could also be great candidates for investigation of their binding abilities to 
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CLA because first row transition metals could potentially suggest wider range of 
applications with their affordable prices. 
 
1.6.5 Noticeable examples of peptides (preferably cyclic) coordinating with 
transition metals 
 Rather than exhaustively list every single example showcasing cyclic/linear 
peptides with similar number/sequence of amino acid residues as CLA coordinating 
with transition metals from literature, this section emphasize on those that were 
reasonably well cited, preferably with a crystal structure, as well as provided insights 
and enlightenments for organometallic chemists to design their own transition metal 
based complexes using CLA.  
 Among articles containing the concept of cyclolinopeptides, the one got most 
cited (106 citations) is by the Lippard group from MIT. They showcased Pt-based 
complex incorporating peptides with promising cancer therapeutic properties (Scheme 
1.9).84 The peptides involved were linear peptides with fewer amino acid residues 
than CLA; however, the structure of their Pt-based precursor inspired us in the design 
of our Pt-based complex using CLA, which will be described in detail in Chapters 
3.3.1. 
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Scheme 1.9. Synthesis of Lippard’s Pt-peptide complex for cancer treatment. 
This scheme is adapted from reference 84. 
  
In Pt-themed peptide related research, other references could only enlighten us 
to some extend: there is one great example demonstrating efficient liquid-phase 
synthesis of cyclic metallopeptides from linear peptides bearing functional platinum 
complexes, and the 1H NMR spectrum indicated a much more symmetrical species 
after the cyclization.85 We didn’t find any reported crystal structure for Pt-based 
complexes. The majority of characterization methods involved MS (Mass 
Spectrometry), NMR, and EPR (Electron Paramagnetic Resonance). 
 
 While no X-ray structure of a Pt complex incorporating cyclic peptide(s) has 
been reported, in Pd-themed peptide related research last least one class of Pd 
complex has been reported with crystal structure successfully obtained with smaller 
peptides.86, 87 The scope of this reaction extended to Ni and Cu, and the crystal 
structure of the Cu analogue was successfully obtained four years later by another 
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research group (Scheme 1.10).88 Characterization of this type of reaction is very 
comprehensive, possibly because of the small size of peptides involved in the 
reaction. 
 
Scheme 1.10. Synthesize of Pd or Cu based complex incorporating small peptides. 
This scheme is adapted from reference 88. 
 
 Contemporaneously, crystal structure of Cu incorporating the larger sized 
peptide, asciacyclamide, was also successfully obtained. This structure has two 
copper ions separated by a bridging carbonate anions embedded in the saddle-shaped 
ascidiacyclamide ligand. The copper ions in the complex are further coordinated to 
three nitrogen donors, and a deprotonated amide, and to two water molecules (Figure 
1.8).89 The affinity of the ascidiacyclamide-copper complex for carbonate is 
especially interesting and has suggested that these metal cyclic peptide conjugates 
could be involved in the activation and transport of CO2 in vivo for specific 
biochemical processes. 
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Figure 1.8. Bis-copper(II) complex of asciacyclamide.  
Figure is adapted from reference 89. 
  
One advantage of copper coordination chemistry is that without the crystal structure, 
EPR and colour changes (UV/Vis) of the copper complexes could still provide 
valuable insights about the reaction progress/mechanism. Comba et al. fully utilize 
these two characterization methods for patellamide A derivatives and their copper (II) 
complexes (Scheme 1.11).90  
 
Scheme 1.11. Cu(II) complex incorporating patellamide A derivatives.  
This scheme is adapted from reference 90. 
  
26 
 
To summarize, almost no examples from the literature in the area of transition 
metal complexes incorporating peptides (preferably cyclic) showed application in 
organometallic chemistry. In the meantime, very few examples successfully obtained 
crystal structure, and it might just be the nature of transition metal complexes 
incorporating peptides being unfavorable to crystalize from solution. Without a crystal 
structure, all the alternative characterization methods such as MS, EPR, UV-Vis are 
promising but provide limited insights as to where exactly the transition metals are 
coordinated to the in peptides, also these alternative characterization methods possess 
higher potential risk of being misinterpreted. Due to the inherent poor crystallinity of 
larger cyclolinopeptides, we anticipate it would be difficult to obtain crystal structures 
of CLA coordination complexes with transition metals. 
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Chapter 2. Ring-opened palladacycles for applications in C-C coupling reactions 
2.1 Abstract 
 The metallocyclic ring in a monomeric iminoisoindoline-based palladacycle 
[(2-iminoisoidoline)PdCl(PCy3)] (3) can be ring opened by coordination of 
phosphine to form the trans bis(phosphine) iminoisoindoline-based palladium(II) 
complex [(η1-iminoisoidoline)PdCl(PCy3)2] (4) where the η
1
-iminoisoindoline is 
attached only by an Ar-Pd bond. The ring-opened analogue showed significantly 
higher coupling activity in Suzuki coupling reactions with aryl chlorides than any 
iminoisoindoline-based palladacycle studied to date. These results are compared to 
existing monomeric palladacycles and reported acyclic analogues. 
 
2.2 Introduction 
2.2.1 Iminoisoindolines 
N,N′-Diaryliminoisoindolines have the general structure shown in Figure 2.1. 
They are easily synthesized in one step by reaction of phthalaldehyde with two 
equivalents of a primary arylamine. 
 
 
Figure 2.1. General structure of N,N′-diaryliminoisoindolines 
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 The synthesis of N,N′-diaryliminoisoindolines was first reported in 1909 and 
in the last century only 24 papers have been published concerning their synthesis and 
applications,1 the most comprehensive of which have been published by the Takahashi 
group.2-4 Despite their ease of synthesis, diaryliminoisoindolines have never 
previously been investigated as ligands prior to the Foley group’s initial studies.5-8 A 
likely reason for the lack of interest in diaryliminoisoindolines is simply that they are 
not naturally occurring products and thus have been of limited interest to 
organic/bioorganic disciplines. They are, however, well suited to coordinate to 
palladium via the imine nitrogen and to undergo subsequent C-H activation via 
orthopalladation to form the corresponding palladacycles (Scheme 2.1). The Foley 
group has previously reported the synthesis of a series of air and moisture-stable N,N′- 
Diaryliminoisoindoline-based palladacycles. These complexes were investigated as 
pre-catalysts in the activation of aryl chlorides for the formation of biphenyls and 
cinnamates in Suzuki and Heck coupling reactions. N,N′-Diaryliminoisoindolines 
have also recently been investigated by the Karminski-Zamola group for their 
antiproliferative activity.9 
 
Scheme 2.1. General reaction for formation of iminoisoindoline-based palladacycles 
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2.2.2 Palladacycles 
 The definition of palladacyle could be found at Figure 1.1 in Chapters 1.1.1.10 
Since their first application in catalysis in 1995, palladacycles have rapidly emerged 
as dominant precatalysts for a large variety of coupling reactions due to their ease of 
preparation, air and moisture stability, low loading and high activity.10-19 The active 
catalyst in palladacyclic mediated coupling reactions likely involves the reduction of 
the Pd(II) precursor to Pd(0) by initial arylation of the Pd(II) species by arylboronic 
acid to form the arylated palladacycle. The palladacycle then undergoes a ring-
opening process followed by reductive elimination of the arylated ligand.20-24 Despite 
the presumed formation of nanoparticles and elimination of the ligand forming the 
palladacycle, the nature of the palladacycle precatalysts still has a dramatic effect on 
the activity of the system in coupling reactions. Studies have suggested that while 
Pd(0) nanoparticles are formed in coupling reactions involving palladacycles, the 
nanoparticles themselves are not the active species, but represent the catalyst resting 
state from which low-coordinate monomeric homogeneous catalysts can be formed 
via complexation Pd(0) to free ligands in solution.25-27 If this supposition holds true in 
our systems, on way to increase catalyst activity would be to preform a ring-opened 
analogue to a given palladacycle and evaluate the destabilized system in coupling 
reactions, wherein the rate of ligand elimination to form Pd(0) species should greatly 
increase. 
 The objective of this work was thus to synthesize a monomeric ring-opened 
iminoisoindoline-based palladium complex derived from the analogous monomeric 
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palladacycle and compared its activity in Suzuki coupling reactions to that of the 
initial palladacycle. Monomeric phosphine-ligated palladacycles have been 
demonstrated to be considerably more active for Suzuki coupling reactions than their 
dimeric chloride or acetate bridged palladacyclic precursors. In particular, PCy3 
adducts of monomeric palladacycles have shown increased activity for the coupling of 
arylchlorides.12-19, 28-30 Surprisingly, very few palladacycles have been ring-opened 
with Lewis bases to yield their well-defined acyclic analogues. The only examples 
that came even close to this idea were discussed in depth in chapter 1.3 with scheme 
1.7 by the Bedford group and scheme 1.8 by the Likhar group.28-30 
 In this work, a monomeric iminoisoindoline-based palladacycle incorporating 
PCy3 was investigated as a pre-catalyst in the Suzuki coupling reaction with the 
activated aryl chlorides 4-chlorobenzylaldehyde and deactivated aryl chlorides 4-
chloroanisole. The synthesis of ring-opened palladium analogue incorporating an η1-
iminoisoindoline and two equivalents of PCy3 was explored. The resulting ring-
opened acyclic palladium complex was fully characterized by multi-nuclear NMR 
spectroscopy, mass spectrometry and X-ray crystallography. The new acyclic 
palladium complex was found to be highly active in Suzuki coupling reactions 
involving aryl chlorides even in the presence of water. 
 To the best of our knowledge, this work represents the only example of a 
conversion of a monomeric palladacycle to its ring-opened analogue, allowing for a 
direct comparison between the two species in C-C coupling reactions. 
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2.3 Results and discussion 
2.3.1 Cyclopalladation and subsequent ring-opening of the metallocycle 
 Following procedures previously published by our group, reaction of 
phthalaldehyde with two equivalents of aminoacetophenone resulted in formation of 
iminoisoindoline 1 (Scheme 2.2). Para-substituted iminoisoindoline 1 was chosen 
because the corresponding dimeric palladacycle 2 reported turnover numbers (TONs) 
up to 100 for the coupling reaction of 4-chlorobenzaldehyde with phenylboronic 
acid.6 As well, the acyl groups provide an effective NMR handle to monitor the 
formation of subsequent complexes. While a variety of para-substituted N,N’-
diaryliminoisoindolines have now been reported, we have been unsuccessful in 
synthesizing the analogous meta-substituted N,N’-diaryliminoisoindolines by reaction 
of phthalaldehyde with meta-substituted aniline derivatives with such compounds 
remaining unknown in the literature. 
 Subsequent reaction of 1 with Pd(OAc)2 in dichloromethane at room 
temperature resulted in formation of the acetato-bridged, dimeric palladacyclic 
complex 2 with the general formula, [(2-iminoisoindoline)Pd(-OAc)]2 (Scheme 
2.2). The previously reported solid state structures of these complexes show that they 
adopt a characteristic closed book conformation where the two iminoisoindoline 
ligands stacked on top of the other in an anti configuration.6  
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Scheme 2.2. Synthesis of a ring-opened iminoisoindoline-based palladacycle from 
commercially available starting materials 
 
 Dimeric palladacycle 2 was then reacted with an excess of LiCl in acetone 
resulting in an insoluble solid that is presumably the analogous chloride-bridge dimer 
(structural characterization was not performed due to the intractability of the solid). 
Subsequent reaction of the presumed chloride-bridged dimeric palladacycle with one 
equivalent of PCy3 in DCM affords the corresponding monomeric palladacycle 3 with 
the general formula [(2-iminoisoindoline)PdCl(PCy3)]. Treatment of [(
2
-
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iminoisoindoline)PdCl(PCy3)] 3 with another equivalent of PCy3 in DCM yielded the 
acyclic [(η1-iminoisoindoline)PdCl(PCy3)2] complex 4 as a yellow solid in 
quantitative yield from 3.  
 A characteristic indication of the formation of a monomeric species with 
iminoisoindolines is the observed 1H NMR resonance for the CH2 protons of the 
iminoisoindoline ring. In dimeric complexes, the methylene protons are diastereotopic 
resulting in formation of two doublets. Complex 4 shows a singlet at 6.36 ppm for 
two protons indicating the methylene protons are now chemically equivalent and the 
new complex has an average Cs symmetry in solution. This is a downfield shift from 
the analogous 1H NMR resonance in 3 at 5.21 ppm. The free iminoisoindoline ligand 
1 also shows a singlet which is considerably upfield relative to complex 4 at 5.01 
ppm. The 31P NMR spectrum of 4 shows a singlet at 19 ppm consistent with only one 
isomer being present in solution and a trans orientation of the two PCy3 ligands. The 
analogous 31P chemical shift for the monomeric palladacycle 3 appears at 37 ppm.
 Complex 4 is stable at room temperature under an inert atmosphere for at least 
four weeks, however, upon exposure to air at room temperature it slowly decomposes 
to form [(2-iminoisoindoline)PdCl(PCy3)] 3 along with formation of Cy3P=O due to 
reaction with ambient O2 as evidenced by 
1H and 31P NMR studies. The reaction with 
O2 is slow with 30% decomposition observed after 3 days exposure to ambient 
atmosphere. This is in contrast to the Likhar group’s benzothiophene-based acyclic 
diphosphine analogue which is reported to be air and moisture stable (Scheme 1.8 in 
chapter 1.3).30 
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2.3.2 Crystal structure of [(η1-iminoisoindoline)PdCl(PCy3)2] (4) 
 Suitable crystals of 4 were grown by slow evaporation from a 50:50 
dichloromethane/hexane solution at room temperature. An ORTEP plot for complex 4 
is shown in Figure 2.3 and included in its caption are selected bond distances and 
angles. The crystal structure of 4 exhibits a monomeric species with a distorted 
square-planar coordination geometry around the palladium atom and a trans 
disposition of the two PCy3 groups. The Pd-C bond distance is 2.008(4) Å which is 
essentially identical to that of the palladacyclic [(2-iminoisoindoline)PdCl(PCy3)] 
type complexes like 3 which all exhibit Pd–Cpalladate bond distances at 2.00(1) Å (we 
have previously reported the crystal structure of a complex very similar to 3, but with 
H in place of the COMe groups on the aromatic rings). The two Pd-P bond distances 
in 4 are 2.390(1) and 2.369(1) Å which are longer than the corresponding Pd-P 
distance of 2.290(1) Å in [(2-iminoisoindoline)PdCl(PCy3)] type complexes 
consistent with a trans influence of zero in 4 versus the strong trans influence of PCy3 
in [(2-iminoisoindoline)PdCl(PCy3)]. 
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Figure 2.2. ORTEP plot of 4 at the 50% probability level. The cyclohexyl groups on 
the PCy3 ligands have been omitted for clarity. Selected bond lengths [Å] and angles 
[°]: Pd(1)-C(10) = 2.008(4), Pd(1)-P(1) = 2.3687(11), Pd(1)-P(2) = 2.3901(10), Pd(1)-
Cl(1) = 2.4022(10), C(10)-Pd(1)-P(1) = 91.30(11), C(10)-Pd(1)-P(2) = 91.40(11), 
P(1)-Pd(1)-P(2) = 166.68(4), C(10)-Pd(1)-Cl(1) = 174.69(10), P(1)-Pd(1)-Cl(1) = 
88.51(4), P(2)-Pd(1)-Cl(1) = 89.99(4). 
 
2.3.3 Catalytic studies 
 Suzuki coupling reactions of alkyl chlorides with phenylboronic acid provide a 
simple way to screen new precatalysts for C-C coupling activity and compare the 
results to that reported in the literature with other palladium-based systems. Suzuki 
reactions involving the coupling of simple aryl iodides or bromides have become 
somewhat trivial with many precatalysts reporting high TONs in the hundreds of 
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thousands or even in the millions. For example, Bedford’s group has reported that a 
phosphinite-based palladacycle is active for the Suzuki coupling of 4-
bromoacetophenone with a TON of 475 million.13 As far as we know, this represents 
the world record in terms of absolute TON for any Suzuki reaction. A TON of 
910,000 is also achieved for the coupling of the electronically deactivated substrate 4-
bromoanisole. However, the same catalyst reports a TON of only 6 for the coupling of 
aryl chloride 4-chloroanisole.31 
 The coupling of aryl chlorides remains challenging, with most palladacycles 
reporting TONs of only up to 100 for activated aryl chlorides. For example, within 
our own iminoisoindoline-based palladacycles, dimeric palladacycle 2 exhibits TONs 
of 100 for the coupling of 4-chlorobenzylaldehyde with phenylboronic acid. The TON 
falls down to only 20 when deactivated aryl chloride 4-chloroanisole is used. That 
being said, there are of course exceptional catalysts in the literature, however they 
remain a very rare breed. For example, one of the best Pd-based catalysts for Suzuki 
reactions involving aryl chlorides is a [(NHC)PdCl2]2 system from Nolan’s group 
which requires only 0.1% catalyst loading with 1 h reaction times at ambient 
temperature for deactivated aryl chlorides.32, 33 The most active catalyst that we know 
in terms of absolute TON for the Suzuki coupling of 4-chloroanisole is a long-lived, 
π-acidic, phosphite-based palladacycle from Bedford’s group which achieved TONs 
of up to 128,000 after 2 days of reaction time.34 4-Chloroanisole is often used as a 
benchmark coupling substrate as it is difficult to couple due to its electronically 
deactivated nature resulting in a significant resistance to undergoing oxidative 
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addition reactions. 
 Catalytic activity of precatalysts 2-4 was initially evaluated in the Suzuki 
coupling reaction of phenylboronic acid with 4-chlorobenzaldehyde to produce 1,1’-
biphenyl-4-carboxaldehyde (Table 2.1). Suzuki coupling reaction conditions consisted 
of 1,4-dioxane as solvent, Cs2CO3 as base and a reaction temperature of 80 C. These 
reaction conditions are commonly applied to new precatalysts and allow for direct 
comparison of previously published results in the general literature. No attempt to 
optimize the nature of the base or solvent was performed (these conditions often end 
up being the best conditions in systems where solvent and base optimization was 
undertaken).  
 Compound 3 showed 85% conversion after 4 h at 1.0mol% Pd loading with 
complete conversion observed after 24 h. A maximum TON of 3800 was achieved 
with 0.01% catalyst loading although % conversion greatly decreased with decreasing 
mol % Pd (Table 2.1). Acyclic [(η1-Iminoisoindoline)PdCl(PCy3)2] 4 was 
considerably faster than 3, achieving quantitative yields for the coupling of 4-
chlorobenzaldehyde after only 2 h at 1.0% Pd loading. Acyclic complex 4 also 
achieved higher TONs than palladacycle 3 with TONs up to 4700 being observed 
after 16 h. Precatalyst 4 was active when water was added to the reaction mixture, 
achieving quantitative yields at 1.0% catalyst loading however longer reaction times 
of 4 h were required. Complex 4 was even active when water was used as the only 
solvent for the reaction, achieving quantitative yields in 17 h. Complex 3 was inactive 
in the presence of water. These TONs are up to 50 times higher than those observed 
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for dimeric palladacycle 2 (Table 2.1). 
 
Table 2.1. Suzuki coupling of 4-chlorobenzaldehyde with phenylboronic acid.a 
aReaction conditions: 1.0 mmol aryl halides, 1.5 mmol phenylboronic acid, 2.5 mmol Cs2CO3, 5 mL of dioxane. 
bDetermined by 1H NMR in reference to dodecahydrotriphenylene as internal standard. 
 
Entry Catalyst  
(mol % Pd) 
Time (h) Conversion 
(%)b 
TON 
(mol product/mol Pd) 
1 2 (1.0) 24 100 100 
2 3 (1.0) 4 85 85 
3 3 (1.0) 24 100 100 
4 3 (0.1) 24 87 870 
5 3 (0.01) 24 38 3800 
6 4 (1.0) 2 100 100 
7 4 (0.02) 16 93 4700 
8 4 (1.0)c 
c(in presence of 1 mL water) 
4 100 100 
9 4 (1.0)d 
d(water as solvent) 
17 100 100 
 
Catalytic activity of acyclic precatalyst 4 was next evaluated in the 
challenging coupling reaction of electronically deactivated 4-chloroanisole (Table 
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2.2). TONs of up to 1900 were achieved with 0.02 % Pd loading. This result is two 
orders of magnitude better than that for dimeric palladacycle 2 which exhibits a TON 
of only 20 and an order of magnitude better than monomeric palladacycle 3. 
 
Table 2.2. Suzuki coupling of 4-chloroanisole with phenylboronic acid.a 
aReaction conditions: 1.0 mmol aryl halides, 1.5 mmol phenylboronic acid, 2.5 mmol Cs2CO3, 5 mL of dioxane. 
bDetermined by 1H NMR in reference to dodecahydrotriphenylene as internal standard. 
 
Entry Catalyst  
(mol % Pd) 
Time 
(h) 
Conversion 
(%)b 
TON 
(mol product/mol Pd) 
1 2 (1.0) 24 20 20 
2 3 (0.1) 24 18 180 
3 4 (0.1) 24 96 960 
4 4 (0.02) 24 38 1900 
 
Aryl chlorides with substituents on the ortho positions are also challenging 
substrates to couple with arylboronic acids. The steric hindrance inhibits Pd-Ar bond 
formation and subsequent formation of the new C-C bond in the final coupled 
product. We initially investigated acyclic complex 4 in the coupling of 2-chloro-1,3-
dimethylbenzene with phenylboronic acid. At 0.25 % catalyst loading, quantitative 
yields were obtained after 24 h with a TON of 400 (Scheme 2.3). We then extended 
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this chemistry to include ortho substituents on the arylboronic acid. The coupling 
reaction of 2-chloro-1,3-dimethylbenzene with o-tolylboronic acid also showed good 
activity with a TON of 97. However extending the coupling of bulky substrates to 2,6-
dimethylphenylboronic acid was unsuccessful and indicated the limit to which bulky 
substrates could be coupled with complex 4. 
 
Scheme 2.3. Reaction of ortho substituted aryl chlorides with arylboronic acids 
 
2.4 Conclusions 
Monomeric iminoisoindoline-based palladacycle 3 can be ring-opened by 
reaction with PCy3 to form the acyclic 4. By destabilizing through inhibiting chelating 
effect of the 2-iminoisoidoline ligand in 3, we anticipated an increased activity for 
the Suzuki coupling reactions of aryl chlorides. While we have no evidence for 
nanoparticle formation, the reaction rate for complex 4 dramatically increased as did 
overall TON relative to that of palladacycle 3. This increase in activity is especially 
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pronounced when compared to dimeric palladacycle 2, where 4 is more active by up 
to two orders of magnitude. [(η1-iminoisoidoline)PdCl(PCy3)2] (4) demonstrated 
excellent activity for the coupling of activated and deactivated aryl chlorides and was 
even active when water was used as the sole reaction medium in contrast to its 
precursors to 3 which demonstrated no activity in water. Complex 4 also showed good 
activities in the coupling of bulky substrates. One of the main features when using 
palladacycles such as [(2-iminoisoidoline)PdCl(PCy3)] (3) as precatalysts is that they 
are usually air and moisture stable and can be stored under ambient atmosphere. 
While the acyclic analogue 4 was more reactive, the disadvantage of using the ring-
opened complex was its reactivity with O2 necessitating storage under inert 
atmosphere. 
 
2.5 Experimental 
2.5.1 General 
Unless otherwise stated, all reactions were performed under N2 using standard 
Schlenk techniques or in a N2-filled drybox. All reaction temperatures for catalytic 
reactions refer to the temperature of pre-equilibrated oil or sand baths. 1H and 13C 
{1H} NMR spectra were recorded on a Bruker 500 MHz Avance spectrometer. 
Chemical shifts for 1H and 13C NMR are reported in ppm in reference to the residual 
1H resonances of CDCl3 (
1H: δ 7.26; 13C: δ 77.23). Coupling constants are given in 
Hz. Elemental analyses were performed on a Perkin-Elmer 2400 CHN elemental 
analyzer. Pd(OAc)2 was purchased from PMO Pty Ltd, Australia. All other chemicals 
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were purchased from the Sigma-Aldrich Chemical Company and used as received. 
The syntheses of ligand 1 and palladacycles 2 and 3 have previously been reported.5-8  
Their synthesis has been included below due to minor changes in their preparation 
and improved yield as a result of this research. 
 
2.5.2 Synthesis of iminoisoindoline (1) 
Phthalaldehyde (2.31 g, 17.2 mmol), 4’-aminoacetophenone (4.37 g, 36.1 
mmol), formic acid (0.05 mL) and methanol (30 mL) were combined in a 100 mL 
Schlenk flask equipped with a stir bar. The solution was stirred for 12 h at room 
temperature during which the iminoisoindoline precipitates out of solution. The 
resulting precipitate was isolated by filtration, washed with methanol (3 × 20 mL) and 
then dried under vacuum to obtain a yellow solid in 90% yield (5.70 g). 1H NMR 
(CDCl3, ppm): 𝛿 8.11 (d, J =8.4, 2H, Ar), 8.01 (d, J = 8.8, 2H, Ar), 7.99 (d, J = 8.3, 
2H, Ar), 7.50 (d, J = 7.5, 1H, Ar), 7.45 (m, 1H, Ar), 7.11 (m, 1H, Ar), 7.05 (d, J = 8.3, 
2H, Ar), 6.78 (d, J = 7.6, 1H, Ar), 5.01 (s, 2H, CH2), 2.63 (s, 3H, COCH3), 2.59 (s, 
3H, COCH3). 
 
2.5.3 Synthesis of [Pd(iminoisoindoline)(𝛍-OAc)]2 (2) 
Iminoisoindoline 1 (0.650 g, 1.77 mmol) and Pd(OAc)2 (0.436 g, 1.94 mmol, 
1.1 equiv) were dissolved in dichloromethane (30 mL) in a 100 mL Schlenk flask 
equipped with a stir bar. After 12 h of stirring at ambient temperature, the reaction 
mixture was filtered through Celite to remove palladium black. The filtrate was 
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concentrated and hexane (30 mL) was added to precipitate the desired palladacycle. 
The resulting pale brown precipitate was isolated, washed with cold hexane (3 × 
10mL), and dried under vacuum to obtain 2 in 42% yield (0.437 g). 1H NMR (CDCl3, 
ppm): (anti and syn isomers are observed in solution with the anti isomer being the 
dominant form); anti-isomer: δ 8.26 (s, 2H, Ar), 7.85 (d, J = 8.0, 2H, Ar), 7.53 (m, 
4H, Ar), 7.38 (m, 4H, Ar),  7.10 (d, J = 8.2, 2H, Ar), 7.04 (m, 2H, Ar), 6.36 (d, J = 
8.5, 2H, Ar), 5.95 (d, J = 8.0, 2H, Ar), 5.77 (d, J = 8.1, 2H, Ar), 4.76 (d, J = 16.8, 2H, 
CH2), 3.82 (d, J = 16.8, 2H, CH2 ), 2.58 (s, 6H, COCH3), 2.56 (s, 6H, COCH3), 1.66 
(s, 6H, CH3COO). 
 
2.5.4 Synthesis of [(2-iminoisoidoline)PdCl(PCy3)] (3) 
A flask was charged with [Pd(iminoisoindoline)(μ-OAc)]2 (2) (0.193 g, 0.181 
mmol) and excess LiCl (0.153 g, 3.62 mmol) in  acetone (20 mL) under air and the 
mixture was stirred for 24 h. The resulting yellow precipitate was isolated, washed 
with water (3 x 10 mL) then with acetone (3 x 10 mL) and dried under vacuum. The 
resulting yellow powder then suspended in dichloromethane and reacted with 
equimolar amounts of PCy3 at room temperature. Over the course of 12 h with 
stirring, the yellow suspension gradually became a homogeneous solution. The 
resulting solution was filtered through celite and the solvent was removed under 
vacuum to result in 3 as a yellow powder in quantitative yields. 1H NMR (CDCl3, 
ppm) 𝛿 8.19 (s, 1H, Ar), 7.92 (d, J = 8.7, 2H, Ar), 7.68 (d, J = 8.4, 1H, Ar), 7.61-7.45 
(m, 4H, Ar), 7.11 (m, 1H, Ar), 6.96 (d, J = 8.5, 1H, Ar), 6.48 (d, J = 8.1, 1H, Ar), 5.21 
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(s, 2H, –CH2–), 2.61 (s, 3H, –C(=O)CH3), 2.56 (s, 3H, –C(=O)CH3), 2.22 (m, 3H, 
PCy3), 1.85 (m, 6H, PCy3), 1.71 (m, 6H, PCy3), 1.60 (m, 9H, PCy3), 1.19 (m, 3H, 
PCy3), 1.00 (m, 6H, PCy3). 
31P NMR (CDCl3, ppm) δ 37.31. 
 
2.5.5 Synthesis of [(η1-iminoisoidoline)PdCl(PCy3)2] (4) 
In a 100 mL Schlenk flask equipped with a stir bar, [(2-
iminoisoidoline)PdCl(PCy3)] (3) (0.607 g, 0.770 mmol) was reacted with equimolar 
amounts of PCy3 in dichloromethane (10 mL). The reaction mixture was allowed to 
stir for 2 h following which solvent was removed under vacuum resulting in 
formation of 4 as a yellow powder in quantitative yields. Crystals were obtained by 
slow evaporation from a 50:50 dichloromethane/hexane solution. 1H NMR (CDCl3, 
ppm) 𝛿 8.39 (s, 1H, Ar), 7.92 (d, J = 8.4, 2H, Ar), 7.87 (d, J = 8.4, 1H, Ar), 7.52 (d, J 
= 8.5, 1H, Ar), 7.42-7.35 (m, 2H, Ar), 7.05 (m, 1H, Ar), 6.89 (d, J = 8.3, 2H, Ar), 6.73 
(d, J = 8.0, 1H, Ar), 6.36 (s, 2H, –CH2–), 2.60 (s, 3H, –C(=O)CH3), 2.52 (s, 3H, –
C(=O)CH3), 2.16 (m, 6H, PCy3), 1.96 (m, 12H, PCy3), 1.68 (m, 6H, PCy3), 1.55 (m, 
24H, PCy3), 1.03 (m, 18H, PCy3). 
13C NMR (CDCl3, ppm):  δ 198.34 (−C(=O)CH3),  
197.61 ( − C(=O)CH3), 156.89 (C=N–), 153.98, 149.89, 145.72, 141.56, 131.41, 
131.22, 130.93, 130.46, 130.39, 129.35, 127.56, 126.40, 126.32, 123.62, 122.96, 
122.22, 121.38, 121.12, 57.74 (–CH2–), 31.54 (PCy3), 31.25 (PCy3), 30.27 (–
C(=O)CH3), 30.10 ((–C(=O)CH3), 28.18 (PCy3), 28.03 (PCy3), 27.82 (PCy3), 26.64 
((PCy3). 
31P NMR (CDCl3, ppm) δ  19.02. Elemental analysis (%) calcd. for 
C60H85ClN2O2P2Pd: C 67.34, H 8.01, N 2.62; found: C 66.87, H 7.70, N 2.86. HRMS 
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m/z calcd for C60H85ClN2O2P2Pd: 1068.4810 [M], 753.2801 [M-PCy3-Cl]
+; found 
753.2898 [M−PCy3−Cl]
+. 
 
2.5.6 General procedure for Suzuki coupling reactions 
In a typical run, a 40 mL vial equipped with a stir bar was charged with aryl 
chloride (1.00 mmol), cesium carbonate (2.50 mmol), arylboronic acid (1.50 mmol) 
and the internal standard (dodecahydrotriphenylene, 0.10 mmol). Under nitrogen, the 
mixture was dissolved in 1,4-dioxane (5 mL) and a known mol % catalyst was 
introduced. If the catalyst loading is less than 1%, dilution or multi-step dilution for 
the catalyst was performed other than direct weighing. The dilution was always 
prepared freshly and consumed in the same day to minimize the potential degradation 
of the catalyst in a diluted solution. All trials with catalysts from the diluted solution 
were performed three times to ensure the reproducibility. The reaction mixture was 
sealed with a septum and moved to a pre-heated oil bath at 80 °C. After the specific 
time, a syringe purged with nitrogen was used to take aliquots from the reaction 
mixture to monitor the conversion of the starting material. Solvent was removed 
under vacuum, and the residue was dissolved in CDCl3 for 
1H NMR analysis. Percent 
conversions were determined by 1H NMR against dodecahydrotriphenylene as the 
internal standard. We found that percent conversions could also be determined against 
the remaining aryl halide by comparison of the aldehyde protons as only one product 
is formed (provided the aryl halide is not volatile).  
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2.5.7 X-ray structure determination of complex 4 
Data was collected at -100 C on a Nonius Kappa CCD diffractometer, using the 
COLLECT program.35 Cell refinement and data reductions used the programs 
DENZO and SCALEPACK.36 SIR9737 was used to solve the structures and 
SHELXL9738 was used to refine the structures. ORTEP-3 for Windows39 was used for 
molecular graphics and PLATON40 was used to prepare material for publication. H 
atoms were placed in calculated positions with Uiso constrained to be 1.5 times Ueq of 
the carrier atom for methyl protons and 1.2 times Ueq of the carrier atom for all other 
hydrogen atoms. 
Crystal data. C60H85ClN2O2P2Pd, FW = 1070.11, monoclinic, space group 
P21/c, a = 10.9284(3) Å, b = 25.7450(3) Å, c = 20.7944(6) Å, β = 101.9280(9)
o, Z = 4, 
ρcalc: 1.242 Mg/m
3, 76884 collected reflections, 10123 unique (Rint = 0.1272), Final R 
indices [I> 2σ(I)] were R1 = 0.0521, wR2 = 0.0895. 
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Chapter 3. Cyclinopeptides as selective ligands for light transition metals 
Disclaimer 
 The cyclolinopeptide project was a collaborative work with Pramodkumar 
Jadhav who was a postdoctoral researcher in the Foley group between July 2013 and 
June 2014. Dr. Jadhav’s work was mainly focused on synthesis of platinum and iron 
based complexes utilizing cyclolinopeptide A (CLA) and/or cyclolinopeptide B 
(CLB), while my work only involved CLA because of the scarce supply and lower 
purity of CLB. Dr. Jadhav noticed that CLA and CLB behaved identically when 
binding with the transition metal tested, and thus in some of the contexts in this 
chapter the plural form of “cyclolinopeptide” appeared. Any work in this thesis 
involving platinum and iron were done by Dr. Jadhav, and presenting results from his 
work was only meant to serve a better purpose of providing a comprehensive 
perspective of cyclolinopeptide’s metal binding properties. I do, however, have no 
intention to give any impression that those works were performed by me. Dr. Jadhav’s 
characterization of Pt and Fe complex is very comprehensive, involving NMR, IR, 
UV-Vis, EPR, MS, and Raman spectroscopy; however, none of Dr. Jadhav’s 
spectroscopic or spectrometric data is presented according to the Departmental Thesis 
Writing Policy. XANES (X-Ray Absorption Near Edge Structure) experiments were 
performed by Robert Bauer under the supervision by Dr. Ramaswami Sammynaiken, 
and results were interpreted by Dr. Sammynaiken. 
 To avoid redundancy, I just refer “Dr. Jadhav” as “we” when presenting Dr. 
Jadhav’s work.   
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3.1 Abstract 
 
 Cyclolinopeptides are a group of naturally occurring Caryophyllaceae-type 
cyclopeptide (Type VI) comprised of eight or nine amino acid residues found in 
flaxseed (Linum usitatissimum) oil. In this work, we investigated cyclolinopeptides as 
a new class of ligand for the formation of transition metal complexes. It was 
discovered that these cyclic peptides possess particularly high affinity for the 
formation of first row transition metal complexes versus their heavier congeners. In 
particular, we have observed unusual reaction phenomena with regards to stabilization 
of copper and iron species. Synthesis and applications of these complexes along with 
attempts to make heavier transition metal analogues will be discussed. 
 
3.2 Introduction 
3.2.1 Facts about flax 
 Flax comes from the blue-flowered plant crop grown mainly in the cool, 
northern climate of the western Canadian prairies. Canada is the largest flax producer 
and exporter in the world and Saskatchewan is the major contributor to Canada’s flax 
production.1 Nutritious value is the major contributor for flax’s increasing demand, 
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especially the significant percentages of omega-3 fatty acids found in flaxseed.2 
 
Table 3.1. Production of flax by province in Canada, unit is 103 tons 
Year Manitoba Saskatchewan Alberta Western Canada Total 
2000/2001 205.7 469.9 17.8 693.4 
2001/2002 199.4 495.3 20.3 715.0 
2002/2003 214.6 444.5 20.3 697.4 
2003/2004 195.6 533.4 25.4 754.4 
2004/2005 132.1 355.6 29.2 516.9 
2005/2006 147.3 881.4 53.3 1,082.0 
2006/2007 193.0 759.5 36.3 988.8 
2007/2008 105.4 511.8 16.3 633.5 
2008/2009 161.3 666.8 33.0 861.1 
2009/2010 193.0 708.7 28.4 930.1 
2010/2011 81.3 311.2 30.5 423 
2011/2012 54.6 289.6 54.7 398.9 
2012/2013 66 381 41.9 488.9 
2013/2014 48.3 492.8 73.7 614.8 
2014/2015 99.0 501.2 216.0 816.2 
 
3.2.2 CLA 
 Cyclolinopeptides are a class of cyclic peptides comprised of eight to nine 
amino acid residues found in flaxseed oil. Cyclopeptides are under the category of 
Caryophyllaceae-type cyclopeptide, and cyclopeptide is defined as cyclic compounds 
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formed mainly with the peptide bonds of 2-37 amino acid residues and discovered in 
higher plants.3 Methods of extracting cyclolinopeptides from flax, as well as 
separating them each as a pure substance were successfully developed by Reaney et 
al.4-6 
 Cyclolinopeptide A (CLA) was the first cyclopeptide discovered back in 1959, 
making it also the first cyclolinopeptide discovered.7 Likely reasons for CLA being 
first cyclolinopeptides discovered are (i) CLA is the most abundant among all, (ii) 
CLA is the easiest cyclolinopeptide to be separated and isolated.6 
 CLA has been fully characterized for the past half century, and the sequence of 
CLA was determined as c(Pro-Pro-Phe-Phe-Leu-Ile-Ile-Leu-Val) from early structural 
studies in the 1970s.8-10 The crystal structure of CLA was first reported by Di Blasio et 
al. in 1987,11 followed by several other research groups successfully obtained crystal 
structures in other solvent conditions.12, 13 Figure 3.1 showed a representation of CLA 
that will be used in this thesis. CLA’s crystal structure could be found at Figure 1.5 in 
Chapters 1.6.3. 
 
Figure 3.1. Representation of CLA that is used in this thesis 
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 One major research motivation for CLA is its similar structure to Antamanide 
(Figure 1.6 in Chapters 1.6.3), a homodetic cyclodecapeptide isolated from the 
poisonous mushroom Amanita phalloides, which possesses strong 
immunosuppressive activities.15, 16 Siemion et al. were the first to report CLA’s strong 
immunosuppressive activity in 1991.17 Their follow up study concluded that CLA’s 
immunosuppressive activity was to some extent competitive to another well-known 
immunosuppresor: Cyclosporin A (Figure 1.7 in Chapters 1.6.3).18-20 
 Other than immunosuppressive activities, CLA was also found being able to 
bind with K+, Na+, Ca2+, Mg2+, and Ba2+ from NMR and CD studies, with a binding 
affinity to Ba2+ being the strongest.21 However, this tendency for metal ion 
complexation is strongly reduced compared to Antamanide, 22, 23 and to the best of our 
knowledge no application of the resulting metal ion complex binding with CLA has 
been reported. 
 A Sci-Finder® search performed on April 15, 2015 showed only 190 articles 
contained the concept of cyclolinopeptides, with most entries involved in CLA’s 
structural studies, immunosuppressive studies, as well as structural and 
immunosuppressive studies on synthesized CLA derivatives. Very few articles got 
cited more than 10 times, even for review articles, and there is no example 
showcasing CLA coordinating with transition metals. As organometallic chemists we 
believe there is much of CLA chemistry that remains unexplored. We envisage CLA 
as a naturally occurring, low-toxic, large-sized ligand for transition metals. The 
objective here is to explore its coordination ability, study the structure of the resulting 
62 
 
metal-CLA complexes, and evaluate its catalytic activities if a well-defined system 
can be successfully obtained and characterized. Thus the objective of this project is 
more fundamental in nature consisting of exploring the coordination chemistry of 
CLA to transition metals and subsequently studying their potential reactivity in 
organometallic reactions. 
 
3.2.3 Transition metal complexes incorporating peptides (preferably cyclic) 
 As mentioned previously, there has been no report of transition metal 
complexes incorporating CLA or any other cyclolinopeptides to date. There are 
however several examples of transition metal complexes incorporating peptides. 
These examples are reasonably well cited, and they offered certain enlightenment to 
our own choice of transition metal precursors, as well as choice of characterization 
methods for this project. 
 The Lippard group from MIT showcased Pt-based complexes incorporating 
small linear peptides with promising cancer therapeutic properties (Scheme 1.9 in 
chapters 1.6.5),24 and their structure of Pt precursor inspired us to achieve significant 
breakthroughs in our own Pt-based complexes incorporating CLA (more details in 
3.3.1). 
 Other examples from Pt-themed peptide related research appeared to be much 
less useful; moreover, there has been no report of crystal structures in this area. At 
least there was one reported crystal structure of a Pd-themed peptide related research, 
and in this study the success of obtaining crystal extends to a copper precursor for the 
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same reaction conditions (Scheme 1.10 in Chapters 1.6.5).25-27 
In Cu-themed peptide related research, the crystal structure of Cu 
incorporating a larger sized peptide (asciacyclamide) was also reported.28 
Interestingly, two copper atoms were inside of the ring to accommodate a larger sized 
cyclic peptide (Figure 1.8 in Chapters 1.6.5).  
 One advantage of copper coordination chemistry is that even without a crystal 
structure, EPR and colour changes (UV/Vis) of the copper complexes could still 
provide valuable insights about the reaction mechanism. Comba et al. fully utilize 
these two characterization methods for patellamide A derivatives and their 
corresponding Cu(II) complexes. (Scheme 1.11 in chapters 1.6.5.)29 
 
3.3 Results and Discussions 
3.3.1 Cyclolinopeptide complexes of precious metals 
 It is worth addressing some points at the beginning of this section. The 
quantity of CLA provided for this project is only one gram, and it has been shared 
between Dr. Jadhav and me. To maximize number of trails, almost all the reaction of 
CLA with transition metal precursors were at NMR tube scales to keep the 
consumption of CLA at approximately ten milligrams for each experiment. Since 
those were NMR tube scale reaction, and 1H NMR spectroscopy is an affordable and 
readily available method of characterization, 1H NMR spectroscopy has always been 
involved as one of the characterization methods. Because of the low reaction scale, in 
many cases the reactions took place in deuterated solvents to make the subsequent 
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NMR characterization more convenient. 1H NMR spectroscopy unfortunately could 
not provide us with critical structural assignment of the resulting transition metal 
complex because of the complicated and broad features exhibited in the 1H spectrum 
of CLA. However, change in the 1H NMR spectrum could potentially provide 
valuable insights: Shionoya et al. noticed that the 1H NMR spectrum became much 
more symmetrical when their Pt-based complex incorporating cyclic peptide was 
formed.30 1H NMR spectroscopy could also provide preliminary assessment if the 
oxidation state of the transition metal had changed after complexation: for example, if 
the 1H spectrum of a Cu2+ precursor is very sharp after the introduction of CLA, it 
could indicate that the paramagnetic Cu2+ got reduced to a diamagnetic Cu+ complex. 
 CLA was screened with common palladium precursors to explore its 
coordination properties to palladium. Palladium acetate (Pd(OAc)2) was initially 
selected because of its good availability, relative affordable price, distinct NMR 
signals, as well as good solubility in a variety of organic solvents. In addition, 
Pd(OAc)2 has good thermal stability to a certain degree, at least in the conditions of 
our test: we performed a controlled test by promoting the temperature of Pd(OAc)2  (in 
CDCl3) at 80 
oC for 48 h and observed no sign of decomposition. 
 CLA was first reacted at room temperature with Pd(OAc)2 under a variety of 
stoichiometric conditions (1:2, 1:1, 2:1). No colour change had been observed, nor 
was any change observed by 1H NMR spectroscopy. Significant colour change of the 
reaction mixture would occur only when excess equivalents of Pd(OAc)2 were used 
under elevated temperatures and prolonged reaction times (Scheme 3.1). Peaks 
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between 2.5 to 1.5 ppm in 1H NMR became much sharper, indicating that some 
interaction should have happened. However, ESI-MS was attempted of the resulting 
dark coloured solution but was unsuccessful, neither was the attempt of growing 
crystals out of the solution. 
 
 
Scheme 3.1. Reaction of CLA with Pd(OAc)2 
 
 It was envisaged that by deprotonating the NH proton(s) on CLA, CLA would 
have negatively charged site(s) and thus more accessible for coordination with Pd2+ 
precursors. NaOtBu was first used because of its affordability and strong basic 
property; moreover, it is an non-nucleophilic base that shoud not interfere with the 
process of transition metal binding to CLA. Multiple ratios of NaOtBu to CLA (2:1, 
4:1, 8:1) was studied, but even at eight equivalents of NaOtBu no deprotonation of the 
NH proton that appear at ~7 ppm region on 1H spectrum were observed. Pd(OAc)2 
was introduced after the addition of the base, and reaction at neither room temperature 
nor at an elevate temperature could result in ESI-MS signals to be observed. 
 tBuLi was also used as the base as it is arguably the strongest commercially 
available base. Immediate deprotonation of the NH proton was observed from the 
disappearance of the peaks at around 7 ppm region in 1H spectrum. This resulting 
substance was monitored by 1H NMR 12 h after the initial addition of tBuLi; the 
 CLA was reprotonated after 12 h. As a result, Pd(OAc)2 was introduced twenty 
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minutes after the addition of tBuLi, however, reaction at neither room temperature nor 
at an elevate temperature could allow ESI-MS be successfully obtained. Solvents 
attempted for reactions of Pd(OAc)2 with CLA include CDCl3, C6D6 and DMSO-d6.  
 Other commercially available Pd precursors such as PdCl2 and Pd(MeCN)2Cl2 
suffer from solubility issues: with PdCl2 being insoluble in all CDCl3, C6D6 and 
DMSO-d6 and  Pd(MeCN)2Cl2 is only soluble in DMSO-d6. Despite the solubility 
problem, tests with or without different types of base, as well as at room temperature 
or at an elevated temperature were performed. ESI-MS could not be successfully 
obtained either. 
 It was also envisaged that if a Pd(0) precursor was used, deprotonation of CLA 
wouldn’t be necessary to reduce the energy barrier for CLA to coordinate on the Pd 
atom. However, commonly used commercially available Pd(0) precursor Pd2(dba)3 
decomposed upon contact with CLA. 
 In the meantime, we were working on screening platinum-based precursors for 
reactions with cyclolinopeptides A because platinum, in the same group as palladium, 
shares many chemical similarities; moreover, platinum complexes tent to have 
interesting cytotoxicity properties, particular for cancer therapy. We anticipated that 
once we successfully synthesized well-defined [(CLA)Pt] complexes, our 
collaborators in the College of Pharmacy could perform cytotoxicity studies on them.  
 Initial screening tests with Pt/CLA combinations suffered similar inclusive 
results as palladium analogues, however work done by the Lippard group inspired us 
with the choice of platinum precursors.24 Commercially available Pt(NH3)4Cl2·xH2O 
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happened to share some structural similarities as Lippard’s Pt precursor, and a 
preliminary reaction studying  Pt(NH3)4Cl2·xH2O with CLA was highly promising 
(Scheme 3.2). Inspiration was raised to use the palladium analogue of this platinum 
precursor and replicate the exact same reaction conditions (Scheme 3.3).  
 
 
Scheme 3.2. Reaction of Pt(NH3)4Cl2·xH2O with CLA gives product 1 as 
characterized by ESI-MS 
 
 
Scheme 3.3. Reaction of Pd(NH3)4Cl2·H2O with CLA using exact same condition as 
Scheme 5.1 gives product 2 as characterized by ESI-MS 
 
 CLA is highly soluble in methanol but its solubility decreased drastically in 
water; neither Pt(NH3)4Cl2·xH2O nor Pd(NH3)4Cl2·H2O are soluble in methanol. 
Therefore, a MeOH : H2O = 9 : 1 solution was found to be most feasible to solve the 
solubility problems. Both Pt(NH3)4Cl2·xH2O and Pd(NH3)4Cl2·H2O are white powders 
in solid form and colourless when dissolved by MeOH : H2O = 9 : 1 solution; the final 
Pt and Pd products share the same physical properties as their corresponding 
precursors. This final air and moisture stable palladium complex 2 could be 
characterized by ESI-MS (Figures 3.2 − 3.4) and matches exactly with the calculated 
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isotopic pattern of the chemical formula [C57H85N9O9Pd]
2+  
 
 
Figure 3.2. Full scope of the ESI-MS plot of 2 
 
 
Figure 3.3. Major peak expanded for 2 
 +TOF MS: 1.833 to 2.767 min from hl-140.wiff
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Figure 3.4. Figure 3.3 with calculated isotopic pattern of 2 superimposed on actual 
data for 2 (Dashed lines represent calculated isotope pattern for 2) 
 
 As the case in Scheme 3.2, the ESI-MS plot showed the major peak of 1 fit in 
the description of chemical formula [(CLA)PtCl2 − 2H]
2+ (comparing to the 
[(CLA)Pd]2+ of 2) , the difference of the two chlorine atoms remaines unexplained. It 
was also noticed that despite varying the stoichiometry of CLA and Pt(NH3)4Cl2 (1:2, 
1:1, 2:1) in Scheme 3.2, the final product remained as [(CLA)PtCl2 − 2H]
2+, consistent 
with platinum was coordinated to multiple sites within the CLA ring and not just on 
the outside. 
 Catalytic activity of [(CLA)Pd]2+ complex was evaluated in Suzuki coupling 
reactions using 4-bromoanisole and phenylboronic acid (Scheme 3.4 and 3.5). 
Compared to the palladium precursor Pd(NH3)4Cl2·H2O, the catalytic activity of 
[(CLA)Pd]2+ was slightly improved.  
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Scheme 3.4. Evaluation of catalytic activity of Pd(NH3)4Cl2·H2O using Suzuki 
coupling reactions 
 
 
Scheme 3.5. Evaluation of catalytic activity of 2 formed in situ using Suzuki coupling 
reactions 
  
 The reactions with palladium and platinum complexes all require long reaction 
times, high temperature and the formed complexes were not well-defined species. We 
spent tremendous efforts optimizing the reaction conditions as well as searching 
literature references. It appears to be the nature of the Pd/Pt complexes being not best 
suited for the CLA coordination studies. As mentioned previously, to the best of our 
knowledge, there is no crystal structure reported of Pt complex incorporating linear or 
cyclic peptides, and only one example of Pd in that matter. On the other hand, several 
examples of Cu complex incorporating cyclic peptides have been reported, from a 
smaller cyclic tetrapeptide to a bigger cyclic octapeptide. It seems reasonable to start 
exploring CLA’s interaction with first row transition metals starting with copper. 
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3.3.2 Cyclolinopeptide complexes of first row transition metals 
3.3.2.1 Cyclolinopeptide complexes incorporating copper 
 The Foley group has expertise in copper chemistry, and our understanding of 
copper chemistry allowed us to choose copper as a possibly better candidate with 
CLA because its light transition metal character such as smaller atom size might 
promote coordination with CLA. 
 A preliminary study of Cu(I) precursors with CLA on NMR tube scale 
reactions was performed (Scheme 3.6 and 3.7). CuCl and CuOAc are both insoluble 
in CDCl3. Introduction of 1 equiv. of CLA in the presence of 1 equiv. of CuCl or 
CuOAc in CDCl3 resulted in immediate solubilization of the copper precursor and 
formation of a homogeneous solution. 
 
Scheme 3.6. Reaction of CLA with CuCl in an NMR tube scale reaction 
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Scheme 3.7. Reaction of CLA with CuOAc in an NMR tube scale reaction 
 
 1H NMR spectra were successfully obtained with no broadening, indicating 
that the formed complexes could very likely be Cu(I) complexes. ESI-MS plots were 
also successfully obtained, and it was a significant breakthrough by the 
characterization with ESI-MS that clean peaks with an exact match to the isotopic 
pattern of the chemical formula [(C57H85N9O9)Cu]
2+ could be observed. ESI-MS plots 
(Figure 3.5) using CuOAc as the copper precursor (Scheme 3.6 and 3.7) was shown 
with major peak expansion (Figure 3.6) and was compared to calculated isotopic 
pattern (Figure 3.7). This experiment demonstrated that copper could be a more suited 
metal to react with CLA as the reaction conditions were very mild and the resulting 
ESI-MS plots were as expected.  
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Figure 3.5. Full scope of the ESI-MS spectrum of product 4 
 
 
 
Figure 3.6. Major peak of 4 expanded from Figure 3.5 
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Figure 3.7. Figure 3.6 superimposed with calculated isotopic pattern of 
[(C57H85N9O9)Cu]
2+
 
  
With to the success with Cu(I) precursors, analogues reactions of Cu(II) 
precursors were performed. Reactions with Cu(II) precursors took place virtually 
instantaneously under mild conditions (Scheme 3.8 and 3.9), with a colour change 
from blue/green to a pale yellow colour that was identical to that of the Cu(I) 
experiments (Scheme 3.6 and 3.7). 
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Scheme 3.8. Reaction of CLA with CuCl2 in mild conditions 
 
 
Scheme 3.9. Reaction of CLA with Cu(OAc)2 in mild conditions 
 
 ESI-MS spectrum also confirmed the feasibility of this reaction, with only one 
peak showing as the desire peak (Figure 3.8). The expanded region (Figure 3.9) 
looked identical to the case using Cu(I) as the copper precursor (Figure 3.7); also, the 
isotopic pattern matched exactly as the calculated one using the chemical formula 
chemical formula [(C57H85N9O9)Cu]
2+, which is interpreted as [(CLA)Cu]2+. To avoid 
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redundancy in the following context the major peak expansion from ESI-MS plots 
will be omitted; major peak expansion superimposed with calculated isotopic pattern 
will be kept to serve the same purpose. 
 
 
Figure 3.8. Full scope of the ESI-MS spectrum of product 6 in Scheme 8.2 
 
 It is worth mentioning that for Figure 3.5 there is still excess CLA appearing at 
m/z=1040 region while for Figure 3.8 the plot is remarkably clean.  Weighing Cu(I) 
precursors in a glovebox at very low loading (~ 1mg) resulted the issue of unreliable 
reading of its mass because of electrostatics, while this issue does not apply to 
weighing Cu(II) precursors in open atmosphere. 
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Figure 3.9. Major peak from Figure 3.8 superimposed with calculated isotopic pattern 
of [(C57H85N9O9)Cu]
2+
 
 
 Moreover, the products from Scheme 3.8 and Scheme 3.9 resulted in 1H NMR 
spectra with no peak broadening, indicating that the formed copper complexes are 
most likely diamagnetic; if so, along with the observed colour changes of the reaction 
mixture, it is reasonable to speculate that CLA reduced the Cu(II) precursors to Cu(I) 
during coordination and keep the oxidation state of copper as Cu(I) in this complex.  
 To summarize, significant breakthroughs in Cu-themed coordination chemistry 
with CLA has been accomplished particularly in terms of utilizing ESI-MS as the 
characterization method. It appears that CLA has a significantly higher affinity to Cu-
based precursors compared to Pt and Pd-based precursors, with reactions all taking 
place in mild conditions and virtually no time. Moreover, redox reaction could have 
taken place based on the observation of colour fading from blue/green (Cu(II) 
 +TOF MS: 30 MCA scans from Sample 3 of HL-146-02.wiff
a=3.56988776344751480e-004, t0=-3.36139309400314230e+001 R;
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precursors) to pale yellow (possible Cu(I) complexes incorporating CLA). We were 
motivated to investigate the scope this redox phenomenon to other first row transition 
metals and iron appeared as a good candidate because iron also has more than one 
commonly observed oxidation states; moreover, Fe2+ is not as air sensitive as Cu+. 
 
3.3.2.2 Cyclolinopeptide complexes incorporating iron 
 FeCl3 was tested with CLA under the same mild reaction conditions as Cu(II) 
precursors to explore if any significant colour change would occur. As with Cu(II), 
reaction of Fe(III) with CLA resulted in rapid colour fading and production of NMR 
spectra consistent with a diamagnetic species (Scheme 3.10). These evidences all 
indicated that CLA has reducing ability during coordination with light transition 
metals. Moreover, when Fe(II) was used as the precursor to react with CLA under a 
variety of stoichiometric conditions (Fe:CLA = 1:1, 2:1, 4:1, 1:2), only one peak 
consistent with [(CLA)Fe]2+ was observed, consistent with iron being coordinated to 
multiple sites within the CLA ring and not just on the outside (Scheme 3.11). 
 
Scheme 3.10. Reaction of CLA with FeCl3 in mild conditions 
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Scheme 3.11. Reactions of CLA with FeCl2 in mild conditions under a variety of 
stoichiometric ratios 
 
3.3.2.3 XANES of [(CLA)Cu] and [(CLA)Fe] complexes 
 X-Ray Absorption Near Edge Structure (XANES) were employed to 
determine the oxidation state of copper in complex 6 from Scheme 3.9, complex 7 
from Scheme 3.10 and complex 8 from Scheme 3.11 by Robert Bauer from the 
Department of Physics. The experiments were conducted at 95 K to minimize the 
photo reduction of Cu(II) to Cu(I) during the X-ray absorption. Preliminary results 
from XANES showed that the oxidation state of copper is Cu(I) and the oxidation 
state of iron is Fe(II) in these complexes. Figure 3.10 and 3.11 are provided by Dr. 
Sammynaiken and CPA is a preferred naming than CLA by Dr. Sammynaiken, thus no 
change was attempted in these figures. 
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Figure 3.10. Copper K-edge XANES of [Cu(II)CLA] and [Cu(I)CLA] complexes and 
CuCl2 standard Copper complexes 
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Figure 3.11. Iron K-edge XANES of [Fe(II)CLA] and [Fe(III)CLA] complexes 
 
 The copper shows a significant shift in the edge feature when complexed with 
cyclolinopeptide A. The result may indicate a change in the oxidation state of the 
copper from Cu(II) to Cu(I). An energy shift of ~ 5 eV is sufficient to justify this 
statement.31 Figure 8.1 shows a shift of 2.9 eV of the peak positions, and 3.5 eV of the 
edge onset. This shift is close to 5 eV but not enough to definitively state that there is 
a change in the oxidation state. If the complexes are Cu(I); the intensity of the edge 
peak with respect to the other edge features seems to indicate that both have a 
coordination number of 3, and are either in a T-shaped arrangement or trigonal 
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planar.32, 33 Due to the differences in the features T-shaped seems more likely two 
different bond angles.  More analysis by XANES is required to better conclude the 
oxidation state of copper. 
 The Iron also shows a shift the edge onset of 1.8 eV; between the two 
complexed oxidation states of iron with the cyclolinopeptide A. The shift may 
indicate that the Fe(III) when complexed has a lower affinity for  its electrons 
converting a percentage of the iron to a lower oxidation state Fe(II) complex. The pre-
edge features indicate that the Fe(II) has changed oxidation state having a higher 
percentage of Fe(II) than Fe(III) complex. The Fe(II) pre-edge forbidden transition 
between the 1s and 3d states are indicated by peaks less than ~ 7112.1 eV and Fe(III) 
greater than ~7113.5 eV.34 Figure 8.2 shows that the pre-edge features for both the 
iron complexes indicates that it is most likely a mixture of the two iron oxidation 
states; as described in the paper by Berry et al.35 Further XANES experiments are 
required to verify this. If both oxidation states are presented in the complex, then the 
complex from Fe(II) looks like it has the Td geometry while the Fe(III) complex has 
the Oh geometry. If the iron is in the complexes is Fe(II); the complex from Fe(II) is 
likely C4v geometry and Fe(III) is still likely Oh.
33  
 
3.3.2.4 Cyclolinopeptide complexes incorporating nickel 
 After extensive reactions with palladium precursors and easily successful 
reactions with copper precursors, screening test with nickel was highly anticipated 
since it is in the same group as palladium and only one atomic number less than 
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copper. Preliminary test with NiCl2 were conducted under the same mild conditions as 
reactions with Cu(I) precursors. NiCl2 is insoluble in CDCl3, but the suspension of 
NiCl2 in CDCl3 was easily dissolved with the introduction of CLA, consistent with 
coordination taking place virtually instantaneously (Scheme 3.12).  
 
Scheme 3.12. Reaction of CLA with NiCl2 
 
ESI-MS experiments showed that product 9 also fits in the general [(CLA)M]2+ 
format, with [(CLA)Ni]2+ as the major product peak.  
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Figure 3.12. Major ESI-MS peak of product 9 superimposed with calculated isotopic 
pattern of [(CLA)Ni]2+ 
 
 The left side of Figure 9 shows that the experimental isotopic splitting pattern 
does not match perfectly with the calculated isotopic splitting pattern. One possible 
explanation is that a second complex 10 with the chemical formula [(CLA)Ni−2H]2+ 
coexists with the major product 9. Calculated isotopic pattern for 10 was plotted on 
the ESI-MS plot (Figure 3.13). The ratio between product 9 and product 10 is roughly 
3:1 after calculation by Analyst® QS software. 
 
Figure 3.13. Calculated isotopic pattern of [(CLA)Ni−2H]2+ (product 10) overlapping 
with ESI-MS plot from Scheme 3.12. 
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3.4 Conclusions 
 In conclusion, cyclolinopeptides are a new class of ligand that are completely 
isolated from natural products and can bind with light transition metals with ease. 
Initial results suggest that cyclolinopeptide has the ability to reduce Cu(II) to Cu(I) 
and Fe(III) to Fe(II) during the coordination process. With other transition metals such 
as nickel and cobalt, more than one product could be formed. It appears CLA prefers 
to bind light transition metals over their heavier metal analogues, with palladium and 
platinum precursor all require prolonged heating. The nature of the coordination 
remains unknown, and attempts to grow crystals for X-ray diffraction studies have 
been unsuccessful to date. 
 
3.5 Experimental 
 Unless otherwise stated, all NMR tube reactions were performed under N2 
using standard Schlenk techniques or in a N2-filled drybox. All reaction temperatures 
refer to the temperature of pre-equilibrated oil or sand baths. 1H NMR spectra were 
recorded on a Bruker 500 MHz Avance spectrometer. High resolution HPLC-MS was 
performed on an Agilent HPLC 1100 series directly connected to QSTAR XL Systems 
(Mass Spectrometer Hybrid Quadrupole-TOF LC-MS/MS, Applied Biosystems, 
Toronto, Canada) and electrospray ionization (ESI) was used. Pd(OAc)2 was 
purchased from Precious Metals Online (PMO) Pty Ltd, Australia. All other chemicals 
were purchased from the Sigma-Aldrich Chemical Company and used as received. 
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3.5.1 Synthesis of [(CLA)PtCl2]
2+ (1) 
 CLA (0.010 g, 0.0096 mmol) and tetraamineplatinum(II) chloride hydrate 
(Pt(NH3)4Cl2·xH2O) (0.003 g, 0.001 mmol) were combined in a small vial, 2 mL of 
MeOH : H2O = 9:1 solution was introduced to the vial. The vial was sealed and 
heated at 75 oC for two days. ESI-MS m/z calcd for [C57H83N9O9PtCl2]
2+: 651.265 
[M]2+; found 651.2596 [M]2+. 
 
3.5.2 Synthesis of [(CLA)Pd]2+ (2) 
 CLA (0.012 g, 0.012 mmol) and Pd(NH3)4Cl2·H2O (0.003 g, 0.01 mmol) were 
combined in a small vial, 2 mL of MeOH : H2O = 9 : 1 solution was introduced to the 
vial. The vial was sealed and heated at 75 oC for two days. ESI-MS m/z calcd for 
[C57H85N9O9Pd]
2+: 572.775 [M]2+; found 572.7753 [M]2+. 
 
3.5.3 Synthesis of [(CLA)Cu]2+ (3) 
 CuCl (0.002 g, 0.02 mmol) was suspended in 2mL of CDCl3 in a small vial 
under inert atmosphere at room temperature. CLA (0.012 g, 0.012 mmol) was 
introduced to the suspension and homogenation of the reaction mixture was observed 
overnight. ESI-MS m/z calcd for [C57H85N9O9Cu]
2+: 551.289 [M]2+; found 551.2866 
[M]2+. 
 
3.5.4 Synthesis of [(CLA)Cu]2+ (4) 
 CuOAc (0.0020 g, 0.020 mmol) was suspended in 2mL of CDCl3 in a small 
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vial under inert atmosphere at room temperature. CLA (0.012 g, 0.012 mmol) was 
introduced to the suspension and homogenation of the reaction mixture was observed 
overnight. ESI-MS m/z calcd for [C57H85N9O9Cu]
2+: 551.289 [M]2+; found 551.2866 
[M]2+. 
 
3.5.5 Synthesis of [(CLA)Cu]2+ (5) 
 CLA (0.011 g, 0.011 mmol) and CuCl2 (0.002 g, 0.015 mmol) were combined 
in a small vial, 2 mL of MeOH : H2O = 9:1 solution was introduced to the vial. ESI-
MS m/z calcd for [C57H85N9O9Cu]
2+: 551.289 [M]2+; found 551.2895 [M]2+. 
 
 
3.5.6 Synthesis of [(CLA)Cu]2+ (6) 
 CLA (0.011 g, 0.011 mmol) and Cu(OAc)2 (0.002 g, 0.01 mmol) were 
combined in a small vial, 2 mL of MeOH : H2O = 9 : 1 solution was introduced to the 
vial. ESI-MS m/z calcd for [C57H85N9O9Cu]
2+: 551.289 [M]2+; found 551.2895 [M]2+. 
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Chapter 4. Summary and conclusion 
 The object of part 1 of this M.Sc. thesis was to ring-open a well-defined 
monomeric palladacycle with a strong Lewis base to obtain a well-defined acyclic 
analogue of the palladacycle. The object subsequently extended to perform a direct 
comparison in Suzuki reactions coupling aryl chloride and phenylboronic acid to 
observe a significant improvement in the catalytic activity from the monomeric 
palladacycle to the ring-opened analogue. Follow the scheme shown in Scheme 4.1, 
the monomeric palladacycle 3 and its corresponding ring-opened analogue 4 were 
successfully synthesized, characterized and their catalytic activity were evaluated in 
Suzuki reactions. During this work, the catalytic efficacy of the monomeric 
palladacycle [(2-iminoisoidoline)PdCl(PCy3)] (3) was evaluated and found to be 
more active than the dimeric palladacycle 2. The palladacycle 3 was subsequently 
ring-opened by the strong Lewis base PCy3 to form an acyclic species [(η
1
-
iminoisoidoline)PdCl(PCy3)2] (4). Complex 4 is characterized by MS, NMR and X-
ray studies, all of which were consistent with the anticipated acyclic structure. By 
destabilizing the 2-iminoisoidoline in 3, it was anticipated that an increased activity 
for Suzuki coupling reactions of aryl chlorides would be observed. The reaction rate 
for complex 4 dramatically increased in terms of overall TON relative to that of 
palladacycle 3. This activity enhancement is particularly phenomenal when compared 
to the dimeric palladacycle 2, where 4 is up to two orders of magnitude more active. 
[(η1-iminoisoidoline)PdCl(PCy3)2] (4) exhibited remarkable activity for the coupling 
of activated and deactivated aryl chlorides; moreover, [(η1-
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iminoisoidoline)PdCl(PCy3)2] (4) was even active when water was used as the sole 
reaction medium in contrast to the palladacyclic precursors 2 or 3 which demonstrated 
no activity when water was present. Furthermore, Complex 4 demonstrated great 
activity in the coupling of bulky substrates. One of the main advantages of using 
palladacycles such as [(2-iminoisoidoline)PdCl(PCy3)] (3) as precatalysts is that they 
tolerate air better than complex 4. While the acyclic analogue 4 was more reactive, the 
disadvantage of using the ring-opened complex was its reactivity with O2 
necessitating storage under inert atmosphere. 
 
Scheme 4.1. Synthesis of palladacycle [(2-iminoisoidoline)PdCl(PCy3)] (3) and 
acyclic species [(η1-iminoisoidoline)PdCl(PCy3)2] (4) 
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The other part of this M.Sc. work was to focus on coordination chemistry of 
palladium with CLA. The initial research motivation of this project was to utilize 
CLA isolated from flaxseed oil as a new class of ligand and explored its coordination 
chemistry with palladium, as well as evaluating if the presence of CLA would 
improve the catalytic activity of palladium precursors in Suzuki C-C coupling 
reactions. The reactions of CLA with Pd-based, as well as Pt-based precursors, all 
required harsh reaction conditions, such as elevated reaction temperatures and 
prolonged reaction times. Among all the Pd precursors such as Pd(OAc)2, PdCl2, 
Pd(MeCN)2Cl2, Pd2(dba)3 and Pd(NH3)4Cl2, only Pd(NH3)4Cl2·H2O produced 
appreciable amount of products are characterized by ESI-MS. While the catalytic 
activity of [(CLA)Pd] complexes in Suzuki reactions did improve for the coupling of 
aryl bromides with arylboronic acids versus its Pd(NH3)4Cl2·H2O precursor, the 
improvements are too small to conclude that CLA played any significant role in the 
catalytic mechanism to improve the catalytic efficacy of the resulting [(CLA)Pd] 
complex. Investigation of cytotoxic activities of [(CLA)PtCl2−2H] is still ongoing 
from our collaborators in College of Pharmacy. In contrast, Cu and Fe-based 
complexes incorporating CLA formed virtually instantaneously upon the introduction 
of CLA to the metal under mild conditions, and the ESI-MS showed little to no 
fragmentation being observed. It would be great if the crystal structure studies of the 
resulting complexes were successful to allow us to have a better perspective about 
how exactly transition metals are coordinated to CLA; however, due to the inherent 
poor crystallinity of CLA, it would be difficult in nature to obtain crystal structures of 
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CLA coordination complexes with transition metals. Moreover, it is interesting to 
observe the potential redox ability of CLA to reduce Cu(II) to Cu(I) and Fe(III) to 
Fe(II) as evidenced by colour change, 1H NMR spectroscopy, as well as XANES. 
While more work needs to be done to fully assure this supposition, this work 
represents the first example of a cyclic peptide exhibiting redox properties to the best 
of our knowledge. 
 
Scheme 4.2. Coordination chemistry of CLA with select transition metals 
 
